07Apr 2023
RAF1 contributes to cell proliferation and STAT3 activation in colorectal cancer independently of microsatellite and KRAS status

RAF1 contributes to cell proliferation and STAT3 activation in colorectal cancer independently of microsatellite and KRAS status

The study highlights the crucial role of RAF1, a RAS effector, in the proliferation of both MSI and MSS colorectal cancer (CRC) cells, regardless of KRAS mutation status. A RAF1 transcriptomic signature associated with STAT3 activation was identified, and RAF1 ablation decreased STAT3 phosphorylation in CRC cells. These findings suggest that RAF1 could be a promising therapeutic target for CRC, supporting the development of selective RAF1 degraders for combination therapies in clinical settings.

  • #oncology

Like

Save

Share